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Abstract 19 
A more comprehensive understanding of hepatitis C virus (HCV) transmission dynamics could 20 
facilitate public health initiatives to reduce the prevalence of HCV in people who inject drugs. We 21 
aimed to determine how HCV sequences entered and spread throughout Scotland and to 22 
identify transmission hotspots. A Scottish dataset with embedded demographic data was created 23 
by sequencing the NS5B of 125 genotype (Gt) 1a and 166 Gt3a samples and analysed alongside 24 
sequences from public databases. Applying Bayesian inference methods, we reconstructed the 25 
global origin and local spatiotemporal dissemination of HCV in Scotland. Scottish sequences 26 
mainly formed discrete clusters interspersed between sequences from the rest of the world; 27 
the most recent common ancestors of these clusters dated to 1942-1952 (Gt1a) and 1926-1942 28 
(Gt3a), coincident with global diversification and distribution. Extant Scottish sequences 29 
originated in Edinburgh (Gt1a) and Glasgow (Gt3a) in the 1970s but both genotypes spread 30 
from Glasgow to other regions. The dominant Gt1a strain differed between Edinburgh (cluster 31 
[C]2), Glasgow (C3) and Aberdeen (C4) whereas significant Gt3a strain-specificity only occurred 32 
in Aberdeen. Specific clusters initially formed separate transmission zones in Glasgow that 33 
subsequently overlapped occasioning city-wide co-circulation.  Transmission hotspots were 34 
detected with 45% of samples from patients residing in just nine of Glasgow’s 57 postcode 35 
districts. HCV was introduced into Scotland in the 1940s concomitant with its worldwide 36 
dispersal likely arising from global-scale historical events. Cluster-specific transmission hubs 37 
were identified in Glasgow, the key Scottish city implicated in HCV dissemination. This fine-scale 38 
spatiotemporal reconstruction improves understanding of HCV transmission dynamics in 39 
Scotland. 40 
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Importance 41 
HCV is a major health burden and the leading cause of hepatocellular carcinoma. Public health 42 
needle exchange and “treatment as prevention” strategies targeting HCV are designed to reduce 43 
prevalence of the virus in people who inject drugs (PWID), potentially mitigating the future burden 44 
of HCV-associated liver disease. Understanding HCV transmission dynamics could increase the 45 
effectiveness of such public health initiatives by identifying and targeting regions playing a 46 
central role in virus dispersal. In this study we examined HCV transmission in Scotland by 47 
analysing the genetic relatedness of strains from PWID alongside data inferring the year 48 
individuals became infected and residential information at a geographically finer-scale 49 
resolution than in previous studies. Clusters of Scotland-specific strains were identified with 50 
regional specificity and mapping the spread of HCV allowed the identification of key areas 51 
central to HCV transmission in Scotland. This research provides a basis for identifying HCV 52 
transmission hotspots.   53 
 
 
4 
 
Hepatitis C virus (HCV) currently infects an estimated 180 million people throughout the world. 54 
Following a short acute phase, the virus enters an asymptomatic, chronic stage which can 55 
persist for decades before the potential onset of severe sequelae such as liver cirrhosis and 56 
hepatocellular carcinoma. HCV-associated liver disease is expected to grow exponentially in the 57 
UK over the next decade and will become a major health care burden (1). In developed 58 
countries, HCV transmission occurs predominantly through injecting drug use (IDU). Currently 59 
there is no vaccine against HCV and the new, highly effective direct acting antivirals (DAAs) are 60 
extremely costly. Prevention of new infections is therefore considered the most cost-effective 61 
policy for reducing overall HCV prevalence in PWID (2).  62 
HCV is a significant public health risk in Scotland where the HCV incidence is twice that 63 
of the rest of the UK (3). Of the seven recognised genotypes of HCV, the most prevalent in 64 
Scotland are Gt1 (49%) and Gt3 (46%) (3). Programmes aimed at reducing transmission of the 65 
virus, such as needle exchange initiatives, have been implemented in Scotland since the early 66 
1990s and resulted in decreases in HCV prevalence levels of approximately 16% over six years; 67 
these measures however have proven insufficient to completely control the epidemic (4). 68 
“Treatment as prevention” schemes have been successful in reducing transmission of HIV (5) 69 
and a similar strategy treating HCV-infected PWID with the DAA Telaprevir (Vertex 70 
Pharmaceuticals, Switzerland), interferon and ribavirin has recently commenced in Scotland (J. 71 
Dillon, personal communication). Mathematical models predict that DAA treatment of as little 72 
as 2% of HCV-positive PWID in Edinburgh could reduce the incidence of infection by 26% in 15 73 
years (2). Better tools are required to monitor the effect of intervention strategies on patterns 74 
of local HCV incidence and transmission, including the potential spread of antiviral resistance.  75 
 
 
5 
 
Tremendous advances have been made in recent years inferring viral transmission 76 
dynamics from sequence data, in part through the development of powerful statistical methods 77 
(6). As an extension of this methodology, phylogeographical approaches combine viral genetic 78 
data with information on the time and place of infection in order to reconstruct viral spread 79 
and to quantify viral transmission (7, 8). Transmission hotspots, areas of high incidence of an 80 
infective agent thought to drive its spread, have been exploited to devise novel prevention and 81 
control approaches for various infectious diseases such as cholera and malaria (9). While in-82 
depth studies of HCV transmission dynamics combining sequence data and residential 83 
information are currently limited, some have successfully used social network data as a 84 
substitute for geographical information. A recent study in Australia (10) was the first to identify 85 
a positive association between HCV strain genetic relatedness and reported injecting 86 
relationship. An earlier study in Brazil (11) showed that HCV transmission dynamics in Sao Paulo 87 
differed according to genotype and that social factors play an important role in the spread of 88 
the virus. These studies demonstrate the great potential of phylogeographic inference to 89 
quantify HCV spread from viral sequence data. 90 
In this study we applied Bayesian inference methods to embedded phylogenetic and 91 
demographic data with a threefold purpose: (i) to reconstruct the introduction of the epidemic 92 
HCV genotypes 1a and 3a into Scotland, (ii) to infer the spatiotemporal dispersal of sequences 93 
within Scotland and (iii) to identify hotspots of transmission. Scottish sequences tended to form 94 
discrete clades within global trees with most recent common ancestors (MRCAs) suggestive of 95 
multiple concurrent introductions of HCV in the 1940s. Although a degree of regional strain-96 
specificity has been maintained to the present time, Glasgow was the major source of strains 97 
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disseminated to neighbouring regions. Transmission zones in Glasgow expanded markedly 98 
within a single decade resulting in eventual co-circulation of genotypes and strains. A small 99 
number of districts within Glasgow were identified as key centres of transmission. 100 
 101 
MATERIALS AND METHODS 102 
Study design. We first created a Scottish dataset by sequencing a partial NS5B region of 125 103 
Gt1a and 163 Gt3a anonymised samples from throughout Scotland collected between 2011 and 104 
2014. Subsequently we assembled a dataset comprising sequences from the rest of the world 105 
(RoW) by retrieving and collating all sequences from the NCBI and Los Alamos HCV databases 106 
with information on country of origin and sample year, and covering the same genomic region 107 
as the Scottish dataset. This resulted in a RoW dataset of 381 Gt1a and 47 Gt3a sequences, 108 
three of which were from Edinburgh and were included in the Scottish dataset. The sampling 109 
locations of the RoW dataset were United States of America (N=320; US), Switzerland (N=45; 110 
CH),  Germany (N=14; DE), Brazil (N=1; BR) and China (N =1; CN) for Gt1a and China (N=16), 111 
India (N=9; IN), Pakistan (N=1; PK), Japan (N=1; JP) and United Kingdom, not Scotland (N=17; UK 112 
other) for Gt3a. We reconstructed the origin and spatial distribution of Scottish sequences 113 
within a local and a global context by analysing the embedded phylogenetic, geographical and 114 
epidemiological data contained in these datasets.  115 
Creation of the Scottish Dataset. Samples from HCV-infected individuals were obtained 116 
from two diagnostic labs, the West of Scotland Specialist Virology Centre (WoS-SVC) and the 117 
Edinburgh Specialist Virology Centre (ESVC). Ethical approval was obtained from the NHS 118 
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Greater Glasgow and Clyde Biorepository (application 140) and South East Scotland SAHSC 119 
Human Annotated BioResource (reference No.10/S1402/33) respectively. To maintain 120 
confidentiality, identifiers and clinical data other than partial postcode (PC) data, year of birth, 121 
year commenced injecting and likely route of infection were delinked. Samples diagnosed at the 122 
WoS-SVC were from patients attending clinics throughout Scotland between July 2013 and 123 
March 2014. Extracted RNA was reverse transcribed and amplified using genotype-specific 124 
primers (Table 1) in a nested PCR covering a 695bp (Gt1a) or 679bp (Gt3a) region of the NS5B. 125 
The ESCV samples were collected between April and December 2011, and were treated 126 
similarly but amplified using a combined reverse transcription (RT)-PCR procedure. Amplified 127 
products were visualised by electrophoresis to confirm product presence and size, then Sanger-128 
sequenced. All samples were screened for the presence of Gt1a/Gt3a co-infections utilising 129 
genotype-specific primers and samples from individuals with co-infections (4.1% of samples) 130 
were excluded from the cohort.   131 
An estimation of the average age drug use commenced (21 years) was calculated from 132 
the detailed data on date of birth and year IDU commenced available for 34 Edinburgh subjects. 133 
There was a wide range of ages for the commencement of IDU (14-39 years of age) although 134 
the mean, median and mode (21, 19 and 19 years respectively) ages of these individuals 135 
confirmed that older age groups were unusual. This was applied to all other samples in the 136 
Scottish dataset to give the estimated year of infection (EYI) for these individuals and used in 137 
the phylogeographical analysis within Scotland. As screening of blood samples commenced in 138 
1989 in the UK it is highly likely that individuals who became infected with HCV after this time 139 
acquired the infection through IDU. To enrich for PWID, only samples from subjects born in 140 
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1969 or later or those born before 1969 but who reported drug use as the main risk factor were 141 
included in the analyses on transmission within Scotland.  142 
Study subject demographics. The mean age of individuals was similar for the Gt1a group (38.6 143 
years [SD, 9.0]) and the Gt3a (41.0 years [SD, 9.8]) groups. Information on residential PC district 144 
was captured for all study participants and the finer spatial resolution contained in PC sector 145 
data was available for 85% of samples.  146 
Temporal phylogenetic analyses. Scottish sequences were aligned and edited where required 147 
using SSE version 1.1 (12) and added to the imported RoW sequences to form the global 148 
dataset.  Bayesian MCMC inference was implemented in BEAST v1.8.0 (13) and the output 149 
inspected by the software Tracer v1.6 (14). The HKY nucleotide substitution model (15) with 150 
gamma rate heterogeneity was used throughout with a relaxed uncorrelated lognormal 151 
molecular clock. A Bayesian skyline coalescent model (16) was used as a flexible demographic 152 
prior in all analyses with chain lengths of 200 million. The global, RoW and Scottish datasets 153 
were analysed for each genotype. 154 
Phylogeographic analyses. Geographical regions in the UK are divided into postcodes, 155 
analogous to zip codes, and consist of six or seven alphanumeric characters (e.g. G61 1QH or 156 
EH16 3JG) normally representing a single street. The first letter/s denote the PC region (e.g. G 157 
or EH), the first grouping is the PC district (e.g. G61) and an additional digit is used for PC 158 
sectors (e.g. G61 1).  There are 16 PC regions, 476 PC districts and 1274 PC sectors in Scotland. 159 
Regional PCs included in this study were Glasgow, Paisley (PA), Kilmarnock (KA), Motherwell 160 
(ML), Edinburgh (EH), and Aberdeen (AB) for both genotypes, and Dundee (DD) additionally for 161 
Gt3a. Other regions were not included in the analyses due to small sample numbers (N < 5). 162 
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Maps with PC regions (http://free-postcode-maps.co.uk/) or without (https://maps.google.co. 163 
uk/maps/) were downloaded and utilised with the Scottish dataset. Samples indicating the 164 
cluster group and EYI were located on maps according to PC information; PC districts were used 165 
on maps of Scotland and, for finer resolution, PC sectors were used for Glasgow maps.  166 
Nucleotide sequence accession numbers. All newly generated sequences from this study were 167 
submitted to GenBank and were assigned the accession numbers KR071882 to KR072203. The 168 
HCV sequences that were included in the RoW dataset were downloaded from GenBank and 169 
are shown in the supplemental table S1. The three GenBank sequences used in the Scottish 170 
dataset were AF516368-AF516370. 171 
RESULTS 172 
MCMC analysis. The MRCAs of the global datasets (Table 2) was 1888 (95% highest posterior 173 
density intervals [HPD], 1857-1914) for Gt1a and 1899 for Gt3a (95% HPD, 1857-1914). Lineages 174 
expanded exponentially, with 90% of Gt1a lineages emerging between 1940 and 1965 (Fig. S1); 175 
Gt3a lineages emerged over a longer time period (1935-1975) in two distinct periods peaking in 176 
1940 and 1960 (Fig. S1). The dates of the Scottish and RoW datasets analysed separately for 177 
Gt1a (1918 and 1907 respectively) and Gt3a (1901 and 1897 respectively) paralleled the values 178 
of the global dataset. The evolutionary rate of Gt1a was 1.88 x10-3 substitutions/site/year 179 
(s/s/y) (95% HPD, 1.53-2.29 x10-3 s/s/y), similar to the evolutionary rate of Gt3a (1.65 x10-3 180 
s/s/y; 95% HPD, 1.19 x10-3-2.14 x10-3).   181 
Scottish clusters. For the purposes of this study Scottish clusters were defined as clades 182 
containing > 5 Scottish sequences of which > 70% of sequences were from Scotland. The Gt1a 183 
global dataset contained four Scottish clusters (Table 3), designated C1 to C4, interspersed 184 
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between groups of RoW sequences (Fig. 1A). The most abundant Scottish Gt1a clusters were C2 185 
(N=34, 89% Scottish sequences) and C3 (N=43, 100% Scottish sequences). The MRCAs of the 186 
Gt1a Scottish clusters ranged from 1942 to 1952 (Table 3). It was difficult to interpret the 187 
positioning of the Scottish Gt3a sequences in the context of the global setting as there were 188 
many more Scottish sequences (N=200) than available RoW sequences (N=44, Fig. 1B). We 189 
identified seven Scottish clusters (C1 to C7) containing between 7 and 76 sequences; 72-97% of 190 
sequences in each of these clusters originated from Scotland (Table 3). The Gt3a Scottish 191 
clusters had MRCAs ranging between 1926 and 1942.  192 
Phylogeographical analyses. The frequency of Scottish clusters in each of the major PC regions 193 
was determined. As there was little difference in the types and frequencies of clusters isolated 194 
in the PC regions Glasgow, PA, KA and ML, this data was additionally analysed together as west 195 
central Scotland (WCS, Fig. 2).  The types and frequencies of Gt1a sequence clusters differed 196 
between AB, EH and WCS (Fig. 2A). The predominant clade in AB was C4 (35%), in EH it was C2 197 
(65%) and in WCS it was C3 (51%).  35% of AB sequences belonged to non-Scottish clades 198 
compared to 15% in EH and 12% in WCS. Although none of the EH sequences occurred in clades 199 
unique to that area, the proportion of clades differed considerably from the other regions. The 200 
predominant EH clade C2 (65%) was less frequent in WCS (23%) and AB (12%), and the minor 201 
EH clade C3 (5%) occurred more frequently in WCS (51%) and AB (12%). Geographic-specific 202 
clustering patterns were observed for Gt3a only as regards AB sequences (Fig. 2B). The 203 
predominant AB clade C1 (46%) was represented less in EH (5%) and WCS (7%). Conversely 204 
clade C6 was not observed in AB but constituted 9%, 18% and 22% in EH, DD and WCS 205 
respectively.  206 
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Gt1a transmission in Scotland. The Scottish Gt1a sequences were derived from individuals 207 
residing in 71 PC districts and 85 PC sectors. Sequences indicating strain cluster were 208 
represented on maps according to the residential PC district and EYI of the participant (Fig. S2). 209 
The earliest Gt1a sequences in this study (1970-1981) occurred predominantly in EH and mainly 210 
comprised clade C2 (75%).  Glasgow became the focus of Gt1a transmission in the following 5 211 
years, particularly clade C3, and sequences subsequently spread to the neighbouring regions 212 
PA, KA and ML. Gt1a sequences were not apparent in AB until 1994 with the AB-specific clade 213 
C4. Overall the initial dominant clades in WCS (C3), EH (C2) and AB (C4) persisted and remained 214 
the dominant clades throughout the 42 year period of the study.  215 
Transmission of Gt1a sequences in Glasgow. The dominant Gt1a clades in Glasgow (C2 and C3) 216 
were mapped by residential PC sector to obtain a finer resolution of dispersal within the city 217 
(Fig. 3). Initially C3 sequences were mainly dispersed in the west of the city but transmission 218 
switched to the eastern suburbs in 1988 and after 2000 spread to northern and south-western 219 
districts. Clade C2 was detected later than C3 in Glasgow, with an initial transmission zone in 220 
the south-east and northern suburbs before expanding to inner western suburbs.        221 
Gt3a transmission in Scotland. Sequences from Gt3a Scottish clusters belonged to 98 PC 222 
districts and 126 PC sectors. Samples were classified by strain cluster and represented on maps 223 
by residential PC district and EYI (Fig S3). Before 1980 Gt3a sequences were mainly from 224 
individuals residing in the Glasgow PC area and this genotype did not spread to EH until the 225 
following decade. Transmission did not expand to the other regions of Scotland until the 1990s, 226 
later than Gt1a.  227 
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Transmission of Gt3a sequences in Glasgow. In Glasgow transmission of Gt3a clade C5 228 
occurred in northern PC sectors before 1983 (Fig. 3). In the following decade the transmission 229 
zone expanded to include more northern suburbs and areas in the east and south of the city. 230 
After 1998 C5 was mainly transmitted in central districts. Initial dispersal of clade C6 occurred in 231 
the inner northern suburbs of Glasgow and spread to the north-east and south-west of the city. 232 
Later transmission occurred mainly in semi-rural north-western regions. 233 
Co-circulation of Gt1a and Gt3a clusters in Glasgow. The temporal dispersal of the two major 234 
Gt1a (C2 and C3) and Gt3a (C5 and C6) clusters within Glasgow was reconstructed (Fig. 4). 235 
Between 1974 and 1983, individual strains formed largely separate transmission networks 236 
within the city. These zones expanded in the next 5 years and began to overlap. Co-circulation 237 
of all 4 clades was apparent by 1994 and subsequent transmission occurred mainly within these 238 
regions, suggestive of self-sustaining networks.   239 
Hotspots of HCV infection in Glasgow. There were a sufficient number of Gt1a (N=54) and Gt3a 240 
(N=94) samples from the Glasgow PC region to examine in more detail. Gt1a sequences were 241 
associated with 25/57 Glasgow PC districts and seven of these districts contained >50% of the 242 
sequences (Fig. 5). At a finer resolution, the predominant PC sector locations of Gt1a samples 243 
were G64-9 (7.4%) and G33-2 (5.9%) and the EYI in these sectors was 1997-2008 and 1988-2006 244 
respectively. 51% of cluster C2 sequences were derived from PC districts G32, G42 and G73 245 
whereas C3 was associated with PC districts G33 and G64 (12% each) (data not shown).  The 246 
Gt3a Glasgow samples were from individuals residing in 35 of the 57 PC districts. Six of these 247 
districts each contained >5% of all sequences and accounted for 40% of the total sequences 248 
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(Fig. 5). PC sectors G33-9 (7.4%) and G21-2 (5.1%) contained the most samples and the EYI in 249 
these sectors were 1995-2004 and 1978-1994 respectively. Cluster C5 was associated with PC 250 
districts G21 and G51 (11% each) whereas C6 was associated with the G64 district (19%) (data 251 
not shown). Overall, 45% of samples were from patients residing in nine of Glasgow’s 57 PC 252 
districts and 11% of samples were from just four of Glasgow’s 241 PC sectors, representing a 7-253 
fold increase from the expected. 254 
 255 
DISCUSSION 256 
Bayesian MCMC methods were used to reconstruct the introduction of HCV Gt1a and Gt3a 257 
extant sequences into Scotland from the global pool using the BSP coalescent model (16) which 258 
allows for variable population sizes over time. A Gt1a global dataset containing 506 sequences, 259 
the largest study of its type to date, was used to calculate the evolutionary rate of this genotype 260 
(1.88 x10-3 s/s/y) which was faster than previously determined.  Calculations of evolutionary 261 
rates can be adversely affected by analysing small numbers of sequences and slower 262 
evolutionary rates (1.48 x 10-3, 1.0 x10-3 and 9.05 x10-4 s/s/y) have been calculated in studies 263 
with smaller datasets [N=334 (17), N=111 (18) and N=176 (19) respectively]. Our results suggest 264 
that Gt1a coalesced in 1888 (1857-1914) which confirms a previous report [1900 (1802-1957)] 265 
(18) but pre-dates another comparable study [1920, (19)].  266 
Gt1a lineage expansion principally occurred between 1940 and 1965 and subsequent 267 
sequence clustering displayed geographical-specificity. This time period coincides with the mass 268 
population mixing of World War II, the subsequent return of individuals to their countries of 269 
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origin and the first large-scale parenteral treatments. It can be speculated that these global-270 
scale events were instrumental in the worldwide mixing and spread of a large pool of strains 271 
which then disseminated locally as a consequence of commonplace parenteral treatment and 272 
IDU of the 1960s. Examination of the Scottish dataset within the global context also supports 273 
this theory. The corresponding coalescence dates of the Scottish and global datasets, the 274 
intercalation of Scottish Gt1a clusters amongst RoW sequences and the similarity in dates 275 
between the MRCA of the Scottish clusters and global lineage expansion suggests extant 276 
lineages were introduced into Scotland from multiple independent sources concurrently with 277 
the diversification and dissemination of HCV worldwide.  278 
Subsequent expansion of a proportion of lineages occurred within Scotland and there is 279 
no evidence of onward transmission or new introductions with the exception of the Aberdeen-280 
specific clade C4, which was first detected in this study in the 1990s. Interestingly the MRCA of 281 
C4 with the RoW pool dates to 1928, pre-dating the emergence of other Scottish clusters from 282 
the global pool; it may have remained unobserved earlier due to the small sample numbers 283 
from Aberdeen or, more likely, this strain originates from a country not included in the RoW 284 
dataset. The lack of onward transmission of this strain to other Scottish regions suggests that 285 
Aberdeen may operate within a different network, perhaps linked more closely to international 286 
HCV transmission networks. Although a small city, Aberdeen is a major oil-producing centre 287 
with consequent international population links, including connections to regions where 288 
information on HCV is sparse such as central Asia.    289 
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The RoW dataset for Gt3a consisted of only 44 sequences. Although more NS5B 290 
sequences with data on sampling date and geographic origin were available from international 291 
databases, these sequences were short in length (approximately 300 bp) and/or only partially 292 
overlapped the genome region used in the current study. As short sequences can adversely 293 
affect the calculation of important parameters in MCMC analyses, they were not included in 294 
this analysis.  The evolutionary rate of the Gt3a sequences from the global dataset was 1.65 x 295 
10-3 s/s/y which is slightly faster than previously noted [1.3 x 10-3 s/s/y, (20)]. These sequences 296 
coalesced in 1899 (1865-1932) similar to previous studies [1905 (1851-1932), (21); 1920s, (22)], 297 
but another study has estimated that extant global Gt3a sequences coalesced much earlier, 298 
approximately 300 years ago (20). In the latter study however three sequences from Pakistan 299 
formed a distinct cluster which was phylogenetically distant from the remainder of the 300 
Pakistani sequences and sequences from other countries; without this outlying cluster the 301 
remaining global Gt3a pool coalesces approximately 80 years ago, supporting our findings.  302 
Although robust contextualisation of the Scottish Gt3a sequences within the global 303 
setting was not possible due to the excess of Scottish compared to RoW sequences within the 304 
dataset, the Scottish sequences did however form distinct clusters. Gt3a lineage expansion 305 
occurred in two periods of exponential growth, peaking in 1940 and 1960. The earlier time 306 
period parallels the MRCAs of the Scottish Gt3a clusters (1926 to 1942) and suggests lineage 307 
expansion during World War II was responsible for the introduction of HCV Gt3a into Scotland, 308 
similar to Gt1a. The second peak of Gt3a lineage expansion (1951-1975) suggests that migration 309 
from the Indian subcontinent may be the source of currently circulating Gt3a sequences in 310 
Scotland. Approximately 1% of the Scottish population originates from Pakistan where epidemic 311 
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Gt3a transmission has been shown to have occurred earlier than in any other country (22).  312 
Extant Gt3a strains in the UK are considered to originate from the HCV-endemic Indian 313 
subcontinent (23) via migration which peaked in the 1950s and 1960s and subsequently these 314 
sequences progressed into and expanded within the PWID community (20). Resolving which of 315 
the two time periods led to the extant pool of Scottish Gt3a strains would require an increase in 316 
global Gt3a sequences, particularly from endemic regions of the world.  317 
The transmission of HCV Gt1a and Gt3a within Scotland’s PWID community was 318 
reconstructed. Since the predominant strains differed between the different Scottish regions it 319 
is likely that they represent separate introductory events from the global pool. An alternative 320 
hypothesis for the regional specificity of HCV strains is the variability in the genetic make-up of 321 
the host population in Scotland, as revealed by a recent study which shows separate genetic 322 
clustering of individuals from Aberdeenshire and WCS (24). The earliest HCV sequences in the 323 
study were from individuals living in Glasgow (Gt3a) or Edinburgh (Gt1a) suggesting that these 324 
two major cities constituted initial hubs of infection. Although index Gt1a sequences occurred 325 
in Edinburgh, they were mainly transmitted within that region alone; in contrast widespread 326 
Gt1a transmission in Glasgow occurred ten years later but constituted the dominant cluster 327 
that subsequently spread to surrounding regions. Taken together this suggests that Glasgow is 328 
the key region driving HCV transmission in Scotland.  An analysis of HCV infection hotspots in 329 
Glasgow was performed at a finer geographical precision than previously attempted. A 330 
disproportional amount of sequences were derived from individuals residing in a few PC sectors 331 
in a cluster-specific manner suggesting that these regions represent key individual networks 332 
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that play a central role in HCV transmission within the city. Targeting intervention and 333 
treatment initiatives to these regions could aid their overall effectiveness.  334 
It is curious that despite the co-circulation of both genotypes within Glasgow, co-335 
infection with multiple HCV genotypes is relatively rare in Scotland (25), with an overall rate of 336 
4.1% in the current study. This is supported by a recent modelling study (26) suggesting that 337 
HCV re-infections frequently result in spontaneous clearance and by empirical data from a 338 
number of studies showing re-infection rates in PWID of 2-9% (27-30). Other studies have 339 
suggested that re-infection is much more common in PWID [20-39% (31-33)] and differences 340 
may be due to the provision of needle exchange programmes in the regions studied or 341 
sensitivities of the assays used. If re-infection is a rare occurrence (26), it is unlikely that 342 
sequences from individuals infected before the nationwide dispersal of strains would be 343 
supplanted by a recently imported strain from a different region and newly-infected individuals 344 
would become the main source of such introduced strains. Since the 1990s only a few new 345 
lineages have been imported from the global pool that have undergone onward transmission, 346 
notably the Aberdeen-specific Gt1a cluster C4. It is interesting to speculate whether the 347 
continued geographical restriction of this clade is due to a later introduction into Scotland 348 
subsequent to the full implementation of clean needle strategies or to separate networks 349 
operating in Aberdeen.  350 
The combination of epidemiology data and molecular phylogenetics has been previously 351 
used to construct injecting social networks for the investigation of HCV transmission dynamics 352 
(10). Researchers established an association between reported injecting relationship and HCV 353 
phylogeny but not between genetic and social distance. A disadvantage of this study type is that 354 
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transmission inference is based on phylogenetic data derived from strains of long-standing 355 
infection combined with information on current injecting partners, similar to the 356 
contemporaneous residential data used in the current study. Other investigators have taken 357 
phylogenetic clustering outcome as direct evidence of individual membership in a contact 358 
network (35-39).  359 
Spatiotemporal analysis based on combined phylogenetic clustering data, EYI’s and 360 
residential PC information for each sample was used in this study. There are limitations 361 
associated with utilising this data for time-correlated phylogeographic reconstruction of chronic 362 
viruses such as HCV. Firstly diagnosis normally occurs many years subsequent to infection. To 363 
overcome this drawback we calculated the average age individuals commenced IDU and 364 
surmised HCV infection within the first year of injecting. Studies have suggested that new 365 
initiates to injecting are particularly vulnerable to HCV infection, seroconverting in 366 
approximately 4 months (40). As well as new infections, PWID may experience multiple 367 
exposures to HCV, with the possibility that a new strain may infect and supplant the original 368 
strain, thus affecting the EYI. Recent modelling studies however suggest that HCV re-infection 369 
generally results in spontaneous clearance of the newly infecting strain (26) and this is 370 
supported by experimental data indicating a low incidence of co-infection with more than one 371 
HCV genotype (25). The second limitation arises from combining current residential with 372 
historical EYI data. Studies however suggest that PWID in the UK are not a highly mobile group 373 
of individuals (34, 41, 42). Nevertheless it is likely that the discernment of transmission 374 
networks at a finer temporal and spatial resolution could be achieved by either the availability 375 
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of residential data from the EYI or, alternatively, obtaining samples from newly-infected 376 
individuals in concert with contemporary residential information.  377 
Although we observed a decade of increased transmission commencing in the mid-378 
1980s, this observation may be subject to a degree of sample bias. The average age of HCV-379 
infected individuals was 40 years, equivalent to an EYI in the mid-1990s.  To enrich for samples 380 
from PWID, sequences from subjects with an EYI before 1989, the year widespread testing for 381 
HCV in blood products commenced in the UK, were excluded unless they specifically confirmed 382 
IDU; this has likely resulted in an augmentation of samples from patients born after 1969. 383 
Individuals born in the 1950s (EYI in the 1970s) are subject to naturally higher, age-associated 384 
mortality rates whereas more recently-acquired HCV strains may not be captured in this cohort 385 
of hospital-diagnosed individuals due to the extensive asymptomatic period of HCV infection. 386 
Previous epidemiological studies have however shown a similar pattern of peak HCV 387 
transmission occurring in Glasgow in the 1980’s (4, 34).  388 
Through this research we reconstructed the dispersal of HCV into and throughout 389 
Scotland and successfully identified transmission hotspots that could enable healthcare and 390 
outreach workers to effectively target intervention and treatment as prevention strategies and 391 
monitor the effectiveness of these methods. The accuracy of this strategy could be further 392 
improved by increasing the sample size from individual cities and analysing sequences from 393 
recently-infected individuals with current residential data. Another tool that could help improve 394 
HCV transmission inference studies is next generation sequencing (NGS) which has recently 395 
been investigated for analysing small-scale transmission events and within-patient connections 396 
(43-45). Minor sequence variants in one individual may predominate in a different individual, as 397 
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illustrated by studies of liver transplants in patients with HCV (46, 47), and NGS may enable the 398 
identification of connections involving minority variants which are not apparent using 399 
traditional sequencing techniques. We now intend to utilise NGS methodology to expand this 400 
study, investigating HCV transmission on a UK-wide basis.  401 
In summary, heterochronous HCV sequences were used in this study to determine the 402 
timeline of introduction of extant Gt1a and Gt3a into Scotland from the global pool and to infer 403 
the spatiotemporal distribution of these sequences in the regional setting. Most Scottish 404 
sequences formed discrete clusters interspersed between RoW sequences and the MRCAs of 405 
these Scottish clusters were dated to the period of global exponential lineage expansion. 406 
Although the origin of the two epidemic HCV genotypes in Scotland differed (Gt1a, Edinburgh; 407 
Gt3a, Glasgow), transmission to other regions occurred predominantly from Glasgow. 408 
Geographical specificity of transmitting clusters was apparent, particularly for Gt1a. In Glasgow 409 
individual clusters formed different transmission zones initially but these networks 410 
subsequently overlapped suggesting co-circulation of genotypes and clusters has occurred 411 
throughout the city since the 1990s.  Hubs of infection were detected that likely play a key role 412 
in HCV transmission throughout the city; targeting intervention strategies to these regions 413 
could assist their effectiveness.  414 
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FIGURE LEGENDS 556 
FIG 1 Bayesian time-scaled trees of the global Gt1a (A) and Gt3a (B) datasets with branches 557 
colour-coded according to the country of origin of the sequences. Clusters identified as 558 
containing predominantly Scottish sequences are highlighted and designated C1-C4 (Gt1a) or 559 
C1-C7 (Gt3a).  560 
 561 
FIG 2 Geographical distribution of Gt1a (A) and Gt3a (B) clusters in Scotland. The type, 562 
frequency and number of samples of individual clusters in each geographical region is shown.  563 
 564 
FIG 3 Geographical distribution of sequences within Glasgow. Sequences from the major Gt1a 565 
(C2 and C3) and Gt3a (C5 and C6) clusters are indicated on maps by the last two digits of the EYI 566 
and colour-coded over three transmission periods. The residential PC sectors associated with 567 
sequences are outlined in black. Likely transmission zones over each time period are 568 
highlighted. 569 
 570 
FIG 4 Co-circulation of the major Gt1a and Gt3a clusters in Glasgow. Likely transmission zones 571 
of the predominant Gt1a (C2 and C3) and Gt3a (C5 and C6) clusters in Glasgow are highlighted 572 
over four time periods. Transmission zones are comprised of the residential PC sectors of the 573 
study participants and connecting regions.    574 
 575 
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FIG 5 Map of Glasgow highlighting the predominant residential PC districts of individuals infected with 576 
Gt1a (blue), Gt3a (red) or areas predominant for both genotypes (purple). The percentages of samples 577 
associated with the districts are shown, coloured in blue (Gt1a) and red (Gt3a). Four PC sectors 578 
representing hotspots of transmission are shown within PC districts, coloured by genotype and with the 579 
associated percentage of samples derived from the sector.  Insert shows a map of the complete Glasgow 580 
PC region with the nine predominant PC districts in colour.  581 
 582 
 583 
 584 
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TABLE 1 HCV genotype-specific primers for nested PCR  586 
Genotype Primer Sequence (5’ to 3’) Genome Positiona  
1a CRT ATG AYA CCC GCT GYT TTG AC 8254-8276 
1a CTC CAC AGT CAC TGA GAG CGA YAT 8276-8299 
1a AAT GCG CTR AGR CCA TGG AGT C 9016-8995 
1a CCT GGA GAG TAA CTR TGG AGT G 9040-9019 
3a CRT ATG AYA CCC GCT GYT TTG AC 8254-8276 
3a CTC NAC YGY CAC TGA RCA GGA YAT C 8276-8300 
3a CCA TGG AGT CTT TCA ATG ATT GCT G 9004-8980 
3a CTC TAC TGG AGA GTA ACT GTG GA 9044-9022 
a The genome position with reference to strain H77  587 
  588 
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TABLE 2 Measures of evolution of the HCV datasets 589 
Genotype Dataset N MRCAa Rate (x 10-3 s/s/y)b 
1a Global 506 1888 (1857-1914) 1.88 (1.53-2.29) 
1a Scottish 125 1918 (1882-1951) 1.81 (1.19-2.48) 
1a RoWc 381 1907 (1879-1934) 1.84 (1.39-2.28) 
3a Global 244 1899 (1865-1932) 1.65 (1.19-2.14) 
3a Scottish 200 1901 (1866-1935) 1.62 (1.15-2.15) 
3a RoW  44 1897 (1860-1934) 1.53 (1.04-2.05) 
 590 
a The most recent common ancestor (MRCA) of datasets with the 95% HPD is shown in 591 
parenthesis.  592 
b The evolutionary rate. s/s/y,  number of substitutions/site/year.  593 
c RoW, rest of the world dataset. 594 
 595 
  596 
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TABLE 3 Composition and MRCA of Scottish clusters 597 
Gta Cluster No. of Scottish 
sequencesb 
No. of RoW sequences  
(UK other)c 
MRCAd 
1a 1 14 1 (0) 1949 (1946-1953) 
 2 34 4 (0) 1944 (1932-1956) 
 3 43 0 (0) 1942 (1937-1951) 
 4 8 0 (0) 1952 (1937-1962) 
3a 1 27 6 (6) 1936 (1932-1940) 
 2 5 2 (2) 1939 (1912-1956) 
 3 12 1 (1) 1939 (1925-1954) 
 4 6 2 (1) 1940 (1916-1960) 
 5 72 4 (2) 1936 (1918-1956) 
 6 33 1 (1) 1942 (1915-1963) 
 7 36 5 (3) 1926 (1918-1947) 
 598 
a HCV genotype. 599 
 b Number of sequences contained in Scottish clusters. 600 
c Number of sequences in Scottish clusters originating from the rest of the world (RoW), with 601 
sequences from other parts of the UK excluding Scotland (UK other) shown in parenthesis.  602 
d The most recent common ancestor (MRCA) of each cluster with the 95% HPD shown in 603 
parenthesis. 604 






